Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Practice Guideline
. 2022 Mar 22;98(12):486-498.
doi: 10.1212/WNL.0000000000200030.

Stroke Prevention in Symptomatic Large Artery Intracranial Atherosclerosis Practice Advisory: Report of the AAN Guideline Subcommittee

Tanya N Turan  1 , Osama O Zaidat  1 , Gary S Gronseth  1 , Marc I Chimowitz  1 , Antonio Culebras  1 , Anthony J Furlan  1 , Larry B Goldstein  1 , Nestor R Gonzalez  1 , Julius G Latorre  1 , Steven R Messé  1 , Thanh N Nguyen  1 , Rajbeer S Sangha  1 , Michael J Schneck  1 , Aneesh B Singhal  1 , Lawrence R Wechsler  1 , Alejandro A Rabinstein  1 , Mary Dolan O'Brien  1 , Heather Silsbee  2 , Jeffrey J Fletcher  1
Affiliations
Practice Guideline

Stroke Prevention in Symptomatic Large Artery Intracranial Atherosclerosis Practice Advisory: Report of the AAN Guideline Subcommittee

Tanya N Turan et al. Neurology. .

Abstract

Background and objectives: To review treatments for reducing the risk of recurrent stroke or death in patients with symptomatic intracranial atherosclerotic arterial stenosis (sICAS).

Methods: The development of this practice advisory followed the process outlined in the American Academy of Neurology Clinical Practice Guideline Process Manual, 2011 Edition, as amended. The systematic review included studies through November 2020. Recommendations were based on evidence, related evidence, principles of care, and inferences.

Major recommendations: Clinicians should recommend aspirin 325 mg/d for long-term prevention of stroke and death and should recommend adding clopidogrel 75 mg/d to aspirin for up to 90 days to further reduce stroke risk in patients with severe (70%-99%) sICAS who have low risk of hemorrhagic transformation. Clinicians should recommend high-intensity statin therapy to achieve a goal low-density lipoprotein cholesterol level <70 mg/dL, a long-term blood pressure target of <140/90 mm Hg, at least moderate physical activity, and treatment of other modifiable vascular risk factors for patients with sICAS. Clinicians should not recommend percutaneous transluminal angioplasty and stenting for stroke prevention in patients with moderate (50%-69%) sICAS or as the initial treatment for stroke prevention in patients with severe sICAS. Clinicians should not routinely recommend angioplasty alone or indirect bypass for stroke prevention in patients with sICAS outside clinical trials. Clinicians should not recommend direct bypass for stroke prevention in patients with sICAS. Clinicians should counsel patients about the risks of percutaneous transluminal angioplasty and stenting and alternative treatments if one of these procedures is being contemplated.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Summary Estimate of the Effects of PTAS + AMM Compared to AMM Alone on 30-Day Risk of Recurrent Stroke or Death
AMM = aggressive medical management; PTAS = percutaneous transluminal angioplasty and stenting; SAMMPRIS = Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis; VISSIT = Vitesse Intracranial Stent Study for Ischemic Therapy
Figure 2
Figure 2. Summary Estimate of the Effects of PTAS + AMM Compared to AMM Alone on Recurrent Stroke or Death Beyond 30 Days
AMM = aggressive medical management; PTAS = percutaneous transluminal angioplasty and stenting; SAMMPRIS = Stenting and Aggressive Medical Management for Preventing Recurrent Stroke in Intracranial Stenosis; VISSIT = Vitesse Intracranial Stent Study for Ischemic Therapy
See this image and copyright information in PMC

References

    1. De Silva DA, Woon FP, Lee MP, Chen CP, Chang HM, Wong MC. South Asian patients with ischemic stroke: intracranial large arteries are the predominant site of disease. Stroke. 2007;38:2592-2594. - PubMed
    1. Wong LK. Global burden of intracranial atherosclerosis. Int J Stroke. 2006;1(3):158-159. - PubMed
    1. White H, Boden-Albala B, Wang C, et al. . Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study. Circulation. 2005;111(10):1327-1331. - PubMed
    1. Gorelick PB, Wong KS, Bae HJ, Pandey DK. Large artery intracranial occlusive disease: a large worldwide burden but a relatively neglected frontier. Stroke. 2008;39(8):2396-2399. - PubMed
    1. Banerjee C, Chimowitz MI. Stroke caused by atherosclerosis of the major intracranial arteries. Circ Res. 2017;120(3):502-513. - PMC - PubMed

Publication types

MeSH terms